Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections.

Autor: Janke, Christian¹ (AUTHOR) christian.janke@lrz.uni-muenchen.de, Rubio-Acero, Raquel¹ (AUTHOR) raquel.rubio@med.uni-muenchen.de, Weigert, Maximilian^2,3 (AUTHOR), Reinkemeyer, Christina^1,4 (AUTHOR), Khazaei, Yeganeh² (AUTHOR), Kleinlein, Lisa² (AUTHOR), Le Gleut, Ronan^5,6 (AUTHOR), Radon, Katja^7,8,9 (AUTHOR), Hannes, Marlene^1,10 (AUTHOR), Picasso, Francesco¹ (AUTHOR), Lucke, Anne Elisabeth^1,4 (AUTHOR), Plank, Michael^1,4 (AUTHOR), Kotta, Irene Charlotte¹ (AUTHOR), Paunovic, Ivana^1,4 (AUTHOR), Zhelyazkova, Ana¹¹ (AUTHOR), Noreña, Ivan¹ (AUTHOR), Winter, Simon^1,4 (AUTHOR), Hoelscher, Michael^1,4,8,10,12 (AUTHOR), Wieser, Andreas^1,4,12,13 (AUTHOR), Küchenhoff, Helmut² (AUTHOR)

Publikováno v: Viruses (1999-4915). Oct2024, Vol. 16 Issue 10, p1556. 20p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections

Autor: Christian Janke, Raquel Rubio-Acero, Maximilian Weigert, Christina Reinkemeyer, Yeganeh Khazaei, Lisa Kleinlein, Ronan Le Gleut, Katja Radon, Marlene Hannes, Francesco Picasso, Anne Elisabeth Lucke, Michael Plank, Irene Charlotte Kotta, Ivana Paunovic, Ana Zhelyazkova, Ivan Noreña, Simon Winter, Michael Hoelscher, Andreas Wieser, Helmut Küchenhoff, Noemi Castelletti, on behalf of the ORCHESTRA Working Group

Publikováno v: Viruses, Vol 16, Iss 10, p 1556 (2024)

This study analyzes immune responses to SARS-CoV-2 vaccination and infection, including asymptomatic cases, focusing on infection risks during the Omicron wave, particularly among high-risk healthcare workers. In the KoCo-Impf study, we monitored 608

Externí odkaz: https://doaj.org/article/eb51db46225d4ed8b0dbe2ad87cc4c57

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia

Autor: Muluneh AG, Merid MW, Gelaye KA, Tilahun SY, Teshager NW, Abereha AY, Sugamo KS, Yimer MA, Kassa GM

Publikováno v: Infection and Drug Resistance, Vol Volume 15, Pp 2409-2416 (2022)

Atalay Goshu Muluneh,1 Mehari Woldemariam Merid,1 Kassahun Alemu Gelaye,1 Sewbesew Yitayih Tilahun,2 Nahom Worku Teshager,3 Aklilu Yiheyis Abereha,4 Kalkidan Samuel Sugamo,5 Mulugeta Ayalew Yimer,3 Getahun Molla Kassa1 1Department of Epidemiology and

Externí odkaz: https://doaj.org/article/9847215c89c448689466a749a6a2c175